However, there might be significant differences in the activity of intracranial disease between patients treated with immunotherapy and TT in retrospective analyses.
← all excerpts
Real-world results of first-line immunotherapy or targeted therapy for metastatic melanoma in Finland: a cohort study.
1
—
—